Joseph J Larosa Net Worth & Insider Trades

Joseph J Larosa - EVP General Counsel and Secret, Regeneron Pharmaceuticals, Inc

As of December 11, 2020

What is Joseph J Larosa's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP General Counsel and Secret, Joseph J Larosa, is estimated to be about $44.96M . Joseph J Larosa owns about 14,725 units of Regeneron Pharmaceuticals, Inc common stock. In the last 9 years at Regeneron Pharmaceuticals, Inc, Joseph J Larosa has sold an estimated value of $45.98M worth.

What is Joseph J Larosa's Past Insider Trading?

Joseph J Larosa's largest purchase order was 20,281 units , worth over $1.2M on March 17, 2015. Joseph J Larosa's largest sale order was 18,311 units , worth over $10.49M on May 15, 2020. In total, Joseph J Larosa has made about 21 transactions over 9 years of their time at Regeneron Pharmaceuticals, Inc. Joseph J Larosa usually trades in December, with the busiest year in 2020. The most recent transaction was a sale order of 10,000 units , worth over $6.15M on August 31, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Joseph J Larosa's' Mailing Address?

  • Mailing address is 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on August 2, 2022 by Marion McCourt who sold 1,100 units worth $639.68K . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.26B and bought an estimated value of $3.4B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1